Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SEPEHR EGRARI

Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery

NPI
1972712644
CMS profile
1074253
Location
BELLEVUE, WA

General Payments · PY2018–2024

$40,312.32

  • Reported across 85 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$450.34

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $450.34 17

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $374.16 14
Galderma Laboratories, L.P. $76.18 3

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $21,484.61 14
PY2019 $17,572.64 14
PY2020 $30.44 2
PY2021 $279.09 11
PY2022 $163.39 9
PY2023 $331.81 18
PY2024 $450.34 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $31.11 01/05/2024 Food and Beverage Undisputed 01/23/2026 1103679281 CMS
ABBVIE INC. $21.81 02/09/2024 Food and Beverage Undisputed 01/23/2026 1103679283 CMS
ABBVIE INC. $33.21 02/23/2024 Food and Beverage Undisputed 01/23/2026 1103679285 CMS
ABBVIE INC. $10.31 03/12/2024 Food and Beverage Undisputed 01/23/2026 1103679287 CMS
ABBVIE INC. $6.38 03/26/2024 Food and Beverage Undisputed 01/23/2026 1103679289 CMS
ABBVIE INC. $33.00 03/26/2024 Food and Beverage Undisputed 01/23/2026 1103679291 CMS
ABBVIE INC. $14.28 03/26/2024 Food and Beverage Undisputed 01/23/2026 1103679293 CMS
ABBVIE INC. $10.81 03/26/2024 Food and Beverage Undisputed 01/23/2026 1103679295 CMS
ABBVIE INC. $10.33 05/30/2024 Food and Beverage Undisputed 01/23/2026 1103679297 CMS
ABBVIE INC. $21.72 05/30/2024 Food and Beverage Undisputed 01/23/2026 1103679299 CMS
ABBVIE INC. $122.42 09/05/2024 Food and Beverage Undisputed 01/23/2026 1103679301 CMS
ABBVIE INC. $29.32 09/19/2024 Food and Beverage Undisputed 01/23/2026 1103679303 CMS
ABBVIE INC. $13.19 10/22/2024 Food and Beverage Undisputed 01/23/2026 1103679305 CMS
ABBVIE INC. $16.27 12/12/2024 Food and Beverage Undisputed 01/23/2026 1103679307 CMS
Galderma Laboratories, L.P. $28.16 02/29/2024 Food and Beverage Undisputed 01/23/2026 1145295947 CMS
Galderma Laboratories, L.P. $25.51 06/13/2024 Food and Beverage Undisputed 01/23/2026 1145295949 CMS
Galderma Laboratories, L.P. $22.51 12/09/2024 Food and Beverage Undisputed 01/23/2026 1145295951 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.